All News

Two pharmacy technicians in Miami were recently arrested on charges of Medicaid fraud. Keep reading to learn more.

A former pharmacist has been convicted of felony conflict of interest charges for taking payments from drug companies and pocketing money for supervising pharmacy interns from Duquesne University.

A recent report by the Coalition Against Insurance Fraud suggests pharmacies and pharmacy regulators need better training and education to help prevent prescription drug diversion, particularly of controlled substance analgesics.

The U.S. Food and Drug Administration now requires the manufacturers of antiepileptic drugs to add a warning that using the drugs increases risk of suicidal thoughts and behaviors.

U.S. Attorney W. Walter Wilkins recently announced Marty Sanders, 34 of Sumter, S.C., was sentenced in federal court on drug charges.

A team of medical investigators at the University of California, San Francisco, has accused drug companies of bias by distorting the results of their trials in medical journals, which many doctors rely on to determine whether to prescribe new drugs.

A patient suit against Wyeth Pharmaceuticals may open brand name drug makers to liability for mishaps when patients take a generic product.

The U.S Food and Drug Administration is investigating whether some asthma medications, in rare cases, can increase the risk of serious asthma complications.

The U.S. Food and Drug Administration recently recalled two unapproved and uncleared devices whose manufacturers claimed could treat various medical conditions. The recall was a Class 1, which means there is a reasonable probability that the use of a device will cause adverse reactions, including death.

Cedarville University, in southwestern Ohio, is moving forward with plans for its pharmacy school, which will begin enrolling students next fall, and has appointed Marc A. Sweeney as the founding dean.

Walgreens and Phillip Morris both recently requested injunctions to stop enforcement of San Francisco?s ban on selling tobacco products in pharmacies.

21st century pharmacy: Everyone's frustrated and services suffer.

A survey of new Rx, new OTC, new indications, and new generics

Exclusive DT survey: Pharmacies are selling more OTC headache medications.

Despite challenges from a contracting economy, pharmacists are optimistic about 2009.

An Ohio hospital automates its pharmacy with an integrated medication management database.

FDA approves Gamunex for treatment of neurologic disease.

A young pharmacist gets a lesson in caring that lasts a lifetime.

A study says that pharmacy workers may be affected by dangerous levels of drug dust. The study's funder may have a remedy for that.

Northern Michigan Regional Hospital is the first hospital in the country to win certification in waste management.

The Pharmacy Museum Foundation of Texas is donating 4,000 pieces of pharmacy memorabilia to Feik School of Pharmacy at University of the Incarnate Word in San Antonio, Texas.

The searchable database will include information on all drug products available in the United States.

For a $10 enrollment fee, customers can fill 90-day prescriptions on any of 400 generic drugs for $9.99.

A civic group has collaborated with Georgia Power and Home Depot to provide price discounts on emergency generators to pharmacies in the community of Buckhead, Georgia.

PharmMD will provide medication therapy management services to 265,000 HealthSpring members. Company pharmacists will use technology to watch for drug interactions and monitor drug regimens.

Deaths from C. difficile increase yearly

Pharmacists hope to speed approvals of off-label medication uses

Disposal of unused medications and other controlled substances is an expensive logistical challenge. Pouring controlled substances into sewer systems is harmful. Incineration costs are prohibitive.

Pharmacists shouldn't be so quick to disregard articles published in alternative medicine journals because the medicine is new or more "mystic" than traditional medicine, according to a study presented by Zara Risoldi-Cochrane, PharmD, resident at the Center for Drug Information and Evidence-based Practice, School of Pharmacy & Health Professions, Creighton University, Omaha, Nebraska.

The niches that aliskiren and nebivolol, two newly approved therapies for hypertension, will occupy in the therapeutic armamentarium for hypertension remain unknown until more outcomes data are obtained with these agents, said Stuart T. Haines, PharmD, BCPS, FASHP, professor, University of Maryland School of Pharmacy, Baltimore, in his discussion of new and emerging therapies for hypertension.